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Ferroxidase activity in human H-chain ferritin has been studied with the aid of site-directed mutagenesis. A site discov- 
ered by X-ray crystallography has now been identified as the ferroxidase centre. This centre is present only in H-chains 
and is located within the four-helix bundle of the chain fold. 
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1. INTRODUCTION 
Ferritin molecules are tetraeicosameric proteins 
housing a mineral known as ferrihydrite in a large 
(7.8 nm diameter) internal chamber [l]. The 
mechanisms of iron storage in vivo are uncertain, 
but in vitro iron-core formation in ferritin involves 
the oxidation of Fe(I1) and hydrolytic polymeriza- 
tion of Fe(II1) [l-5]. Previous work suggests that 
the ferritin protein shell provides catalytic centres 
where Fe(I1) oxidation is accelerated [3,7] and 
nucleation centres which promote the formation of 
ferrihydrite [5]. However, it has also been shown 
that Fe(I1) can be directly oxidized on the surfaces 
of mineral particles once nucleation has occurred, 
thus apparently making the protein ferroxidase 
centres redundant for iron-core growth [5,7]. On 
the other hand, if the pH is lowered to 6 or below, 
iron oxidation and hydrolysis can only proceed in 
the presence of ferritin [6,7]. Neither oxidation nor 
nucleation centres have so far been identified. 
Since Fe(III), catalytically produced in the presence 
of ferritin at pH 6.0, can be transferred to the pro- 
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tein transferrin, it has been proposed that the fer- 
roxidase centres are on or near the outside surface 
of the protein shell [6]. However, recent work with 
ferritins, bearing amino acid sequence changes in 
the 3-fold inter-subunit channels, suggests that an 
internal site may be more likely [8]. 
Most of the earlier work on the mechanism of 
ferritin formation had been performed with horse 
spleen ferritin [3,6]. Like most ferritins, it is a 
heteropolymer of two types of polypeptide chain, 
known as H and L [9]. Horse spleen ferritin con- 
tains mainly L-chains, with only lo-W70 H-chains 
[9]. It has recently been shown with the aid of 
recombinant ferritins [lo] that ferroxidase activity 
is associated with H-chains and not L [7, Ill, con- 
firming earlier work [12]. Nevertheless, human L- 
chain recombinant homopolymers can take up iron 
slowly at pH 7.0 to form Prussian blue-stainable 
ferritin even in the absence of ferroxidase centres 
Pll. 
Through a combination of X-ray crystal- 
lography, production and isolation of site-directed 
mutant proteins and biochemical studies we are 
now able to locate the ferroxidase centre at a 
specific site on human H-chains. 
Details of the X-ray analysis of the human fer- 
ritin H-chain recombinant, CdM, will be given 
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elsewhere. This recombinant bears a single amino 
acid sequence change (Lys 86 -+ Gln) to induce 
crystallization by formation of intermolecular 
metal bridge contacts. The recombinant was shown 
to have assembled correctly and to be active in iron 
uptake [8,13]. Its structure [14] is very similar to 
that of horse spleen apoferritin [l] and rat liver L- 
chain recombinant [15], but an electron density 
map calculated at 2.5 A resolution shows a new 
metal-binding site [ 151. Its three amino acid ligands 
are Glu 27, Glu 62 and His 65 (H-chain number- 
ing). These residues are conserved in all known H- 
chain sequences, but are absent from L-chains (see 
[2]). We have introduced two additional changes 
into recombinant CdM, namely Glu 62 + Lys and 
His 65 + Gly (H to L subunit changes) and show 
that this altered protein (described as 222) has lost 
its ferroxidase activity. 
2. MATERIALS AND METHODS 
The expression and isolation of recombinant human H-chain 
ferritins, the monitoring of purity and assembly by native and 
denaturing gel electrophoresis and the addition of iron were all 
carried out as described in [8]. Iron was also added at 1000 
Fe(II) atoms/apoferritin molecule at pH 7.0 and uptake 
monitored by gel electrophoresis and staining with ferrocyanide 
as in [7,11]. Ferroxidase activity was assayed via the transferrin 
reaction as in [6,7]. 
3. RESULTS AND DISCUSSION 
Fig. 1 shows the results of electrophoresis in 6% 
polyacrylamide gels of human H-chain mutant 
222, CdM, horse spleen ferritin and recombinant 
rat liver ferritin. 0.4 mM ferrous ammonium sul- 
phate was added to the proteins in 0.1 M Mops 
buffer (pH 7.0) to give approx. 1000 Fe 
atoms/molecule and the samples left for 3 h before 
electrophoresis. At that time all the samples had 
the same characteristic brown colour of ferritin. 
The reconstituted ferritins were stained for protein 
and iron (fig.la,b, respectively). Mutant 222 
migrated like CdM and had also taken up some 
iron, although the intensity of the Prussian blue 
stain was less than that of the other ferritins, in- 
cluding the recombinant rat liver L-chain ferritin. 
Possibly some non-specific Fe(I1) oxidation had 
occurred outside the protein shell, since in the same 
experiment, when Fe(I1) oxidation was carried out 
in the presence of bovine serum albumin (BSA) as 
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Fig.1. Electrophoresis of ferritin in a 6% polyacrylamide gel; 
(A) stained for protein with Coomassie blue; (B) stained for iron 
with potassium ferrocyanide. Tracks: (1) horse spleen ferritin, 
(2) recombinant rat L-chain, (3) 222, (4) CdM. 
a protective colloid, no precipitation of iron oxide 
occurred, but the BSA did not stain positively for 
iron. Any iron complex bound to BSA may have 
dissociated during gel electrophoresis. 
The rate at which Fe(I1) was oxidized was studied 
at pH 6.45 and 7.0. Fig.2 shows that, at both pH 
values, the rate of oxidation of 250 Fe(I1) 
atoms/molecule at a concentration of 50 PM Fe, 
was negligible for 222 vs that for either CdM or 
horse spleen apoferritin (measured as increase in 
absorbance at 310 nm). The rate of formation of 
the ferric transferrin complex from apotransferrin 
in the presence of apoferritin was also negligible 
for 222 vs CdM or horse spleen apoferritin, when 
250 Fe(I1) atoms/molecule were added at pH 6.0. 
The formation of an initial Fe(II1) complex, which 
occurred extremely rapidly with CdM, and with 
mutant proteins bearing changes in the 3-fold 
channels at pH 6.45 [8,15], was not observed with 
222 (not shown). 
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Fig.2. Progress curves of iron uptake by H-chain recombinants 
and horse spleen apoferritin. Iron uptake was followed at 
310 nm. 0.05 M Mes (pH 6.4) or 0.05 M Mops (pH 7.0). 50 PM 
Fe(B) and 0.1 mg/ml protein. 
Crystallization trials have yielded small 
(co.1 mm) octahedral crystals of mutant 222. 
These appear morphologically identical to crystals 
of CdM and therefore constitute further evidence 
that correct subunit assembly has taken place. 
The results show that although subunit assembly 
(in mutant 222) had occurred as judged from the 
gel electrophoresis pattern (fig.1) and by 
crystallization, ferroxidase activity had been 
eliminated by the site-directed mutations. Hence, 
we propose that the metal site identified by X-ray 
analysis in H-chains is responsible for the catalytic 
activity. A schematic drawing of this site is shown 
in fig.3. The iron atom has tetrahedral co- 
ordination with protein ligands Glu 27, Glu 62 and 
His 65 and the fourth co-ordination site is oc- 
cupied by a peak in the electron density map that 
may be attributed to a water molecule. This could 
possibly represent the binding site for dioxygen 
during Fe(I1) oxidation. The proposed Fe(II)- 
oxidation site lies within the subunit about 7-10 A 
from the internal surface within the 4-helix bundle 
(shell thickness about 24 A). Communication with 
both outside and inside surfaces of the shell seems 
to be possible by means of narrow channels 
through the protein. These may be the routes by 
which Fe(II1) may migrate outwards to form a 
complex with transferrin (which is too large to 
enter the apoferritin molecule), or inwards to form 
core. Evidence that Fe(II1) migrates from its initial 
oxidation site (in horse spleen ferritin) to form core 
Fig.3. Schematic drawing of proposed ferroxidase centre in 
recombinant H-chain ferritin. 
clusters has been provided by EPR [17] and Moss- 
bauer [ 181 spectroscopy. This migration could be 
aided by displacement of further incoming iron as 
has been suggested previously [ 191. However, it is 
clear that human [ 111 and rat recombinant L-chain 
homopolymers and also mutant 222 (fig.1) are 
capable of taking up iron slowly and forming core 
at pH 7 even in the absence of the oxidation site. 
Significant rates of iron incorporation occur, how- 
ever, only when relatively high iron concentrations 
are employed and under these conditions the inter- 
subunit channels may also be used for entry to the 
cavity. The proposed core nucleation centre could 
be present in both H- and L-chains, and indeed L- 
chains may be superior at promoting core forma- 
tion. However, provided iron can reach the cavity 
and be oxidized inside or en route, polymerization 
would be expected even without direct help from 
the protein, since even a single Fe(II1) atom inside 
the cavity would be at a concentration (approx. 
6 mM) far exceeding the solubility of Fe(II1) at pH 
7 (approx. lo-i2 M). Autocatalytic Fe(I1) oxida- 
tion can be significant once an initial core has been 
established [5,7]. Under cellular conditions, where 
low Fe/apoferritin may be expected, the ferrox- 
idase activity of H-chains may be needed for core 
formation to proceed at a significant rate. The iron 
centre could also perhaps aid the passage of elec- 
trons through the shell for core reduction, but this 
remains to be investigated. 
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